✦ LIBER ✦

Interpretation of Human Epidermal Growth Factor Receptor 2 (HER2) In Situ Hybridization Assays Using 2013 Update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines

✍ Scribed by Bhargava, R.; Dabbs, D. J.

Book ID: 127032507
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 53 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2013.53.9213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

American Society of Clinical Oncology/Co

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

✍ Wolff, A. C.; Hammond, M. E. H.; Schwartz, J. N.; Hagerty, K. L.; Allred, D. C.; 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 279 KB

Impact of American Society of Clinical O

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

✍ Sejal S. Shah; Rhett P. Ketterling; Matthew P. Goetz; James N. Ingle; Carol A. R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Validation and workflow optimization of

Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization

✍ Lim, Sung-Jig; Cantillep, Alegria; Carpenter, Philip M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 909 KB

Chemotherapy and Targeted Therapy for Wo

Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

✍ Partridge, A. H.; Rumble, R. B.; Carey, L. A.; Come, S. E.; Davidson, N. E.; Di 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

Recommendations on Disease Management fo

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline

✍ Ramakrishna, N.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Es 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 114 KB

PIK3CA Mutations Are Associated With Low

PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer

✍ Loibl, S.; von Minckwitz, G.; Schneeweiss, A.; Paepke, S.; Lehmann, A.; Rezai, M 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 274 KB